Cargando…
Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis
The phosphatidylinositol 3-kinase (PI3K)/AKT pathway is frequently upregulated in human cancer. Activation of this pathway has been reported to be associated with resistance to various chemotherapeutical agents. We here used a chemical biology/chemical informatic approach to identify apoptotic mecha...
Autores principales: | Berndtsson, Maria, Hernlund, Emma, Shoshan, Maria C., Linder, Stig |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701489/ https://www.ncbi.nlm.nih.gov/pubmed/19568785 http://dx.doi.org/10.1007/s12154-009-0017-7 |
Ejemplares similares
-
Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes
por: Kippenberger, Stefan, et al.
Publicado: (2009) -
Mechanism of Activation of PKB/Akt by the Protein Phosphatase Inhibitor Calyculin A
por: Pozuelo-Rubio, Mercedes, et al.
Publicado: (2010) -
Deletion of PKBα/Akt1 Affects Thymic Development
por: Fayard, Elisabeth, et al.
Publicado: (2007) -
CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2020) -
Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis
por: Morel, Marion, et al.
Publicado: (2014)